Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cardiac Marker Testing Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cardiac Marker Testing Market, by Product Type, 2020-2030 (USD Billion)
1.2.3. Cardiac Marker Testing Market, by Biomarker Type, 2020-2030 (USD Billion)
1.2.4. Cardiac Marker Testing Market, by Diseases, 2020-2030 (USD Billion)
1.2.5. Cardiac Marker Testing Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cardiac Marker Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cardiac Marker Testing Market Dynamics
3.1. Cardiac Marker Testing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Surge in incidences of cardiovascular diseases
3.1.1.2. Cohesive government initiatives for the diagnosis of cardiac diseases
3.1.2. Market Challenges
3.1.2.1. Technical issues related to sample collection and storage
3.1.2.2. Challenges associated with biomarker assay validation
3.1.3. Market Opportunities
3.1.3.1. Ongoing research on novel cardiac biomarkers for cardiovascular diseases
3.1.3.2. Rising demand for point-of-care (POC) testing
Chapter 4. Global Cardiac Marker Testing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Marker Testing Market, by Product Type
5.1. Market Snapshot
5.2. Global Cardiac Marker Testing Market by Product Type, Performance - Potential Analysis
5.3. Global Cardiac Marker Testing Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Cardiac Marker Testing Market, Sub Segment Analysis
5.4.1. Reagents and Kits
5.4.2. Instruments
Chapter 6. Global Cardiac Marker Testing Market, by Biomarker Type
6.1. Market Snapshot
6.2. Global Cardiac Marker Testing Market by Biomarker Type, Performance - Potential Analysis
6.3. Global Cardiac Marker Testing Market Estimates & Forecasts by Biomarker Type 2020-2030 (USD Billion)
6.4. Cardiac Marker Testing Market, Sub Segment Analysis
6.4.1. Troponin I and T
6.4.2. Creatine kinase-MB(CK-MB)
6.4.3. Brain Natriuretic peptide (Bnp Or Nt-Probnp)
6.4.4. Myoglobin
6.4.5. High-sensitivity C-reactive protein(hs-CRP)
6.4.6. Other Cardiac Biomarkers
Chapter 7. Global Cardiac Marker Testing Market, by Diseases
7.1. Market Snapshot
7.2. Global Cardiac Marker Testing Market by Diseases, Performance - Potential Analysis
7.3. Global Cardiac Marker Testing Market Estimates & Forecasts by Diseases 2020-2030 (USD Billion)
7.4. Cardiac Marker Testing Market, Sub Segment Analysis
7.4.1. Myocardial Infarction
7.4.2. Congestive Heart Failure
7.4.3. Acute Coronary Syndrome
7.4.4. Atherosclerosis
7.4.5. Ischemia
Chapter 8. Cardiac Marker Testing Market, by End User
8.1. Market Snapshot
8.2. Global Cardiac Marker Testing Market by End User, Performance - Potential Analysis
8.3. Global Cardiac Marker Testing Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Cardiac Marker Testing Market, Sub Segment Analysis
8.4.1. Laboratory Testing Facilities
8.4.2. Point-Of-Care Testing Facilities
8.4.3. Academic Institutions
Chapter 9. Global Cardiac Marker Testing Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Cardiac Marker Testing Market, Regional Market Snapshot
9.4. North America Cardiac Marker Testing Market
9.4.1. U.S. Cardiac Marker Testing Market
9.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Biomarker Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Diseases breakdown estimates & forecasts, 2020-2030
9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Cardiac Marker Testing Market
9.5. Europe Cardiac Marker Testing Market Snapshot
9.5.1. U.K. Cardiac Marker Testing Market
9.5.2. Germany Cardiac Marker Testing Market
9.5.3. France Cardiac Marker Testing Market
9.5.4. Spain Cardiac Marker Testing Market
9.5.5. Italy Cardiac Marker Testing Market
9.5.6. Rest of Europe Cardiac Marker Testing Market
9.6. Asia-Pacific Cardiac Marker Testing Market Snapshot
9.6.1. China Cardiac Marker Testing Market
9.6.2. India Cardiac Marker Testing Market
9.6.3. Japan Cardiac Marker Testing Market
9.6.4. Australia Cardiac Marker Testing Market
9.6.5. South Korea Cardiac Marker Testing Market
9.6.6. Rest of Asia Pacific Cardiac Marker Testing Market
9.7. Latin America Cardiac Marker Testing Market Snapshot
9.7.1. Brazil Cardiac Marker Testing Market
9.7.2. Mexico Cardiac Marker Testing Market
9.8. Middle East & Africa Cardiac Marker Testing Market
9.8.1. Saudi Arabia Cardiac Marker Testing Market
9.8.2. South Africa Cardiac Marker Testing Market
9.8.3. Rest of Middle East & Africa Cardiac Marker Testing Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. F. Hoffmann-La Roche AG
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Abbott Laboratories
10.3.3. Danaher Corporation
10.3.4. Siemens Healthineers AG
10.3.5. PerkinElmer, Inc.
10.3.6. BioMerieux SA
10.3.7. Becton, Dickinson and Company
10.3.8. Thermo Fisher Scientific Inc.
10.3.9. Bio-Rad Laboratories, Inc.
10.3.10. Tosoh Corporation
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption